FI105154B - Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan - Google Patents

Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan Download PDF

Info

Publication number
FI105154B
FI105154B FI921111A FI921111A FI105154B FI 105154 B FI105154 B FI 105154B FI 921111 A FI921111 A FI 921111A FI 921111 A FI921111 A FI 921111A FI 105154 B FI105154 B FI 105154B
Authority
FI
Finland
Prior art keywords
group
streptococcus
protein
proteins
dna
Prior art date
Application number
FI921111A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI921111A0 (fi
Inventor
Dennis L Kasper
James L Michel
Frederick M Ausubel
Original Assignee
Brigham & Womens Hospital
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital, Gen Hospital Corp filed Critical Brigham & Womens Hospital
Publication of FI921111A0 publication Critical patent/FI921111A0/fi
Application granted granted Critical
Publication of FI105154B publication Critical patent/FI105154B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI921111A 1989-09-15 1992-03-13 Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan FI105154B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15
US40803689 1989-09-15
PCT/US1990/005251 WO1991004049A1 (en) 1989-09-15 1990-09-14 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS)
US9005251 1990-09-14

Publications (2)

Publication Number Publication Date
FI921111A0 FI921111A0 (fi) 1992-03-13
FI105154B true FI105154B (fi) 2000-06-30

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921111A FI105154B (fi) 1989-09-15 1992-03-13 Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan

Country Status (22)

Country Link
EP (1) EP0491865B1 (no)
JP (2) JPH05500455A (no)
KR (1) KR0180559B1 (no)
AT (1) ATE146081T1 (no)
AU (1) AU641439B2 (no)
CA (2) CA2383393A1 (no)
DE (1) DE69029396T2 (no)
DK (1) DK0491865T3 (no)
ES (1) ES2097154T3 (no)
FI (1) FI105154B (no)
GR (1) GR1002294B (no)
HU (1) HU219327B (no)
IE (1) IE903349A1 (no)
IL (1) IL95578A (no)
NO (1) NO313908B1 (no)
NZ (1) NZ235316A (no)
PL (3) PL167444B1 (no)
PT (1) PT95316A (no)
RU (1) RU2113234C1 (no)
WO (1) WO1991004049A1 (no)
YU (1) YU176490A (no)
ZA (1) ZA907297B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
NZ248766A (en) * 1992-09-24 1996-11-26 Ca Nat Research Council Capsular polysaccharide-protein conjugate vaccine against group b streptococcus type ii or v
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
CN1046291C (zh) * 1993-03-19 1999-11-10 G·林达尔 Rib蛋白、其纯化方法、检测试剂盒及药物组合物
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
WO1999033969A1 (en) * 1997-12-31 1999-07-08 Pincus Seth H A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine
MX2007007033A (es) * 2004-12-22 2007-08-03 Novartis Vaccines & Diagnostic Estreptococus del grupo b.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
EP0302887B1 (en) * 1986-04-16 1994-06-22 The Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines, and methods of manufacture
WO1989000583A1 (en) * 1987-07-17 1989-01-26 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species

Also Published As

Publication number Publication date
PL286898A1 (en) 1991-06-03
NO920942D0 (no) 1992-03-11
AU641439B2 (en) 1993-09-23
IL95578A0 (en) 1991-06-30
EP0491865A4 (en) 1993-05-05
IE903349A1 (en) 1991-04-10
IL95578A (en) 1998-08-16
PL167444B1 (pl) 1995-09-30
HUT63770A (en) 1993-10-28
NO313908B1 (no) 2002-12-23
KR920703097A (ko) 1992-12-17
JP3447713B2 (ja) 2003-09-16
ATE146081T1 (de) 1996-12-15
GR900100692A (el) 1992-01-20
PL167882B1 (pl) 1995-11-30
DE69029396D1 (de) 1997-01-23
ES2097154T3 (es) 1997-04-01
EP0491865B1 (en) 1996-12-11
AU6519090A (en) 1991-04-18
NO920942L (no) 1992-05-12
RU2113234C1 (ru) 1998-06-20
WO1991004049A1 (en) 1991-04-04
CA2066221C (en) 2002-07-23
ZA907297B (en) 1993-06-01
EP0491865A1 (en) 1992-07-01
JP2001309795A (ja) 2001-11-06
FI921111A0 (fi) 1992-03-13
NZ235316A (en) 1992-11-25
KR0180559B1 (ko) 1999-03-20
PL168587B1 (pl) 1996-03-29
DE69029396T2 (de) 1997-06-05
JPH05500455A (ja) 1993-02-04
HU219327B (en) 2001-03-28
YU176490A (sh) 1992-12-21
PT95316A (pt) 1991-06-25
CA2066221A1 (en) 1991-03-16
CA2383393A1 (en) 1991-04-04
DK0491865T3 (da) 1997-06-02
GR1002294B (el) 1996-05-03

Similar Documents

Publication Publication Date Title
US5858362A (en) Conjugate vaccine for group B Streptococcus
FI105154B (fi) Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan
JPH11513371A (ja) 肺炎球菌遺伝子、その一部、それ由来の発現産物、ならびに該遺伝子、該遺伝子の一部分、および該遺伝子産物の使用
AU693175B2 (en) Epitopic regions of pneumococcal surface protein A
EP0866133A2 (en) A group b streptococcus vaccine
AU689452B2 (en) Conjugate vaccine against group B streptococcus
US20080241181A1 (en) Environmentally regulated genes of Streptococcus suis
AU722078B2 (en) Conjugate vaccine against group B Streptococcus

Legal Events

Date Code Title Description
MA Patent expired